Mary Lynne Hedley
Independent DirectorDr. Mary Lynne Hedley, Ph.D., served as Member of Scientific Advisory Board at Duke Street Bio Ltd. until 2025. Dr. Hedley is Member of Board Advisors of argenx SE. She served as Director of Helsinn Healthcare S.A. since April 28, 2021 until 2023. She is an Independent Director of Eli Lilly and Company from May 15, 2022. She serves as a Director of Youville Place. Dr. Hedley served as an Independent Non-Executive Director at Centessa Pharmaceuticals plc (formerly Centessa Pharmaceuticals Limited) since February 22, 2021 until June 24, 2026. She serves as an Independent Director of Veeva Systems Inc. since August 16, 2019. Dr. Hedley co-founded Tesaro, Inc. in March 2010 and served as its President since March 2010 until January 22, 2019 and Chief Operating Officer since July 24, 2014 until January 2, 2019. Dr. Hedley served as the Chief Scientific Officer of Tesaro, Inc. from March 2010 to July 24, 2014. She served as the Chief Scientific Officer and Executive Vice President of Operations at Abraxis BioScience, Inc. from July 2009 to February 4, 2010, responsible for R&D, Operations, Medical Affairs and Business Development. Elsewhere she was Executive Vice President of Eisai Inc, with a focus on the global reorganization of its R&D program and building a global oncology strategy. She served as the Chief Executive Officer, Chief Scientific Officer and President of MGI Pharma Biologics, Inc. She served as the Chief Scientific Officer and Senior Vice President of MGI Pharma, Inc., since October 2005 and served as its Executive Vice President since August 2006. She served as an Executive Vice President of Eisai Corporation of North America following Eisai's acquisition of MGI PHARMA, INC. from January 2008 to July 2009. She joined MGI PHARMA in 2004. She co-founded ZYCOS, Inc. and served as its Chief Executive Officer and President from 1996 to 2004 and also served as Vice President of Research and as Senior Vice President of Research & Development since 1996. She was Director of ZYCOS. She had been an Independent Director of Millendo Therapeutics, Inc. since April 11, 2017 until January 31, 2021. She served as a Director of bluebird bio, Inc. from September 20, 2017 to February 26, 2019. She served as a Directors of Tesaro, Inc. since March 2010 until January 22, 2019. She served as a Director of MGI Pharma Biologics, Inc. She served as a Director of Receptos, Inc. from April 11, 2014 to August 27, 2015. She is a named inventor on multiple patents in the field of immunology and has been widely published in a variety of peer-reviewed journals. She is the recipient of multiple awards and fellowships, is a frequent Guest Lecturer and An Active Volunteer in educational as well as local community organizations. Dr. Hedley's early research career consisted of two consecutive Postdoctoral Fellowships at Harvard University from 1989 to 1996. During her Post-Doctoral studies at Harvard University and in conjunction with other scientists, she co-invented the core technology underlying MGI Pharma Biologics platform. She is Senior fellow and strategic advisor of the Broad Institute of Harvard and MIT since 2021 and Venture Partner of Third Rock Ventures since 2023. She is a Board Member of the Youville Assisted Living Communities and WITH (Women Innovating Together in Healthcare). Dr. Hedley is an immunologist and cancer cell biologist, with a vast level of experience within the pharmaceutical industry, specifically within the field of oncology. She is Co-Inventor of ZYCOS' microparticle delivery technology. Dr. Hedley received a B.S. in Microbiology from Purdue University in 1983 and a Ph.D. in Molecular and Cellular Immunology from UT Southwestern Medical Center, USA in 1988. Following this, Dr. Hedley carried out her postdoctoral training at Harvard University in the areas of Immunology and Gene Regulation.
Positions
- Company NameVeeva Systems Inc.Stock CodeVEEVPositionIndependent DirectorColleagues
- PPPeter P. GassnerFounder, CEO & Director
- GPGordon P. RitterIndependent Chairman of the Board
- ENEleni Nitsa ZuppasPresident & Chief of Staff
- BVBrian Van WagenerChief Financial Officer
- VKVipin KondathChief Accounting Officer
- CACatherine AllshouseChief Information Officer
- MLMarshall L. MohrIndependent Director
- MJMatthew J. WallachIndependent Director
